Cargando…
Predicting Early Disease Recurrence of Pancreatic Cancer following Surgery: Determining the Role of NUDT15 as a Prognostic Biomarker
SIMPLE SUMMARY: Overall survival rates for pancreatic cancer remain poor. Surgery serves as the only curative treatment strategy. A proportion of patients develop early disease recurrence despite undergoing adjuvant chemotherapy. The ability to identify this high-risk patient cohort may allow for a...
Autores principales: | Hughes, Daniel Llwyd, Willenbrock, Frances, Soonawalla, Zahir, Mukherjee, Somnath, O’Neill, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032287/ https://www.ncbi.nlm.nih.gov/pubmed/35448180 http://dx.doi.org/10.3390/curroncol29040206 |
Ejemplares similares
-
Dynamic Physiological Culture of Ex Vivo Human Tissue: A Systematic Review
por: Hughes, Daniel Ll, et al.
Publicado: (2021) -
The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma
por: Wang, Lai Mun, et al.
Publicado: (2015) -
Importance of NUDT15 Polymorphisms in Thiopurine Treatments
por: Tanaka, Yoichi, et al.
Publicado: (2021) -
Circulating biomarkers and outcomes from a randomised phase 2 trial of gemcitabine versus capecitabine-based chemoradiotherapy for pancreatic cancer
por: Willenbrock, Frances, et al.
Publicado: (2020) -
Pharmacogene Variation Consortium Gene Introduction: NUDT15
por: Yang, Jun J., et al.
Publicado: (2018)